Krystal Biotech's market cap is currently ―. The company's EPS TTM is $0.088; its P/E ratio is 1,844.43; Krystal Biotech is scheduled to report earnings on May 6, 2024, and the estimated EPS forecast is $0.30. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 8.60M	-	-	-	$ 0.00
Gross Profit	$ 8.60M	-	-	-	-
EBIT	$ 74.50M	$ -38.05M	$ -48.82M	-	$ -29.85M
EBITDA	$ 75.32M	$ -38.05M	$ -48.12M	-	$ -28.88M
Net Income Common Stockholders	$ 81.24M	$ -33.21M	$ -45.30M	-	$ -29.85M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 562.07M	$ 477.52M	$ 350.39M	$ 379.17M	$ 394.42M
Total Assets	$ 790.35M	$ 684.03M	$ 531.85M	$ 558.45M	$ 576.38M
Total Debt	$ 8.32M	$ 8.54M	$ 8.76M	$ 8.93M	$ 9.12M
Net Debt	$ -553.75M	$ -468.97M	$ -341.63M	$ -370.24M	$ -385.30M
Total Liabilities	$ 34.40M	$ 30.91M	$ 42.28M	$ 36.22M	$ 35.61M
Stockholders Equity	$ 755.95M	$ 653.08M	$ 489.57M	$ 522.23M	$ 540.77M
Cash Flow	-
Free Cash Flow	$ 76.99M	$ -33.21M	$ -31.54M	-	$ -33.74M
Operating Cash Flow	$ -21.23M	$ -33.21M	$ -26.16M	-	$ -19.69M
Investing Cash Flow	$ 105.19M	-	$ 3.56M	-	$ -14.74M
Financing Cash Flow	$ 13.39M	-	$ 1.47M	-	$ 2.12M

Currency in USD

Krystal Biotech Earnings and Revenue History

Income Statement >

Krystal Biotech Debt to Assets

Balance Sheet >

Krystal Biotech Cash Flow

Cash Flow >

Krystal Biotech Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing